News

New research shows that most patients with non-muscle invasive bladder cancer miss critical BCG doses, leading to recurrence.

Enfortumab vedotin plus pembrolizumab has shown potential benefits in patients with MIBC, regardless of eligibility for cisplatin.

A study found that imbalances in estrogen and testosterone signaling are linked to bladder cancer and more advanced disease in women.

Bladder cancer BCG therapy side effects may be reduced by a new hydrogel designed to prevent drug washout and improve treatment tolerance.

Low vitamin D is a consequence, not a cause, of bladder cancer, so vitamin D levels can’t be used to predict bladder cancer risk.

Smoking cigarettes is strongly associated with an increased risk of bladder cancer, while the effects of e-cigarettes needs further research.

Bladder preservation significantly reduced cancer-specific deaths at both two and five years compared with bladder removal in bladder cancer.

People who get a permanent urostomy experience changes in their lifestyle, mental health, social interactions and family relationships.

Receiving five or more installations of Bacillus Calmette−Guérin maintenance therapy within one year may improve bladder cancer survival.

A recent study found limited survival benefits for advanced bladder cancer patients after initial therapy stops working.